Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
CE credit available
Pharmacology credit available

Full Schedule

Full Schedule

  • Sunday, November 6, 2022
  • Advancing Care for Women With HER2+ Metastatic Breast Cancer
  • Benign Hematology: Knowing What Counts
  • Best of Drug Updates Summary Session
  • Best Practices in the Management of Infectious Complications for Patients With Cancer
  • Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
  • Breakthroughs in Surgical Approaches: Gynecologic Oncology
  • Career Negotiation: The Total Package
  • Critical Conversations With LGBTQI+ Populations in the Cancer Setting
  • Critical Lessons in Managing Cancer Pain During the Opioid Epidemic
  • Emerging Approaches in the Management of Challenging Leukemias
  • Managing the Patient With Multiple Primary Tumors
  • Medical Aid in Dying: Ethical and Practical Issues
  • Myeloproliferative Neoplasms: What Advanced Practitioners Need to Know
  • New Drug Updates: Hematologic Malignancies
  • New Drug Updates: Investigational Therapeutics in the Pipeline
  • New Drug Updates: Solid Tumors
  • Panel Discussion: What Does Dobbs v. Jackson Mean for Oncology Patients and Providers? Current Considerations for Pregnancy and Fertility in the Oncology Setting
  • Response to Immunotherapy: Why So Variable?
  • Survivorship and Sexual Health: What the Oncology AP Needs to Know
  • The Importance of Providing Care and Support Tailored to Adolescents and Young Adults With Cancer
  • The Mary Pazdur Award Presentation, Followed by the Keynote Address
  • Thriving With a Rare Metastatic Disease: Surgical Approach to Neuroendocrine Tumors
  • Treatment Selection for Patients With Relapsed/Refractory Multiple Myeloma
  • Uncovering and Addressing Implicit Bias in Oncology
  • Updates in Melanoma
  • Updating the Targeted Therapy Paradigm for Patients With Metastatic NSCLC